Nurse bridge program aims to keep seniors out of hospital

NCT ID NCT02421133

Completed Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a transitional care program for patients aged 75 and older leaving the hospital. A nurse created a care plan, contacted their primary doctor, and arranged a follow-up visit. The goal was to see if this reduces unplanned hospital readmissions or emergency visits within 30 days. 630 patients took part across several hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: transitional care program
What this could lead to: If successful, this program could reduce avoidable hospital readmissions in older adults, improving their recovery at home.
What could go wrong: This is a completed study, so results are available but may not apply to all hospitals or patients. The intervention is complex and may be hard to replicate widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GERIATRICS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GERIATRICS

Contacts and locations

Locations

CH Bourg-en-Bresse

Bourg-en-Bresse, 01012, France
CH Gériatrique des Monts d'Or

Albigny-sur-Saône, 69250, France
CH Saint-Chamond

Saint-Chamond, 42400, France
CH Villefranche

Villefranche, 69655, France
CHG Annecy

Pringy, 74374, France
Centre Hospitalier Alpes Léman

Contamine-sur-Arve, 74130, France
Centre Hospitalier Lyon Sud

Pierre-Bénite, 69495, France
Clinique des portes du sud

Vénissieux, 69200, France
Hôpital Édouard Herriot

Lyon, 69437, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.